Search results
Moderna Breaks Out For The First Time In A Year After Covid Shot Wallops Sales Views
Investor's Business Daily· 40 minutes agoBut it can be serious or deadly in babies and older adults. The FDA is due to make its decision on ...
Moderna Reports Smaller Than Expected Q1 Loss, Prepares For RSV Vaccine And Spikevax 2024-2025...
Benzinga via Yahoo Finance· 2 hours agoThursday, Moderna Inc (NASDAQ:MRNA) reported a first-quarter EPS loss of $(3.07), down from an...
Moderna loses less than expected as Covid vaccine sales beat estimates, cost cuts take hold
CNBC· 10 hours agoModerna on Thursday posted a narrower-than-expected loss for the first quarter as the company's...
Moderna COVID vaccine sales plummet 91 percent - The Boston Globe
The Boston Globe· 6 hours agoSales of Moderna’s COVID-19 vaccine plunged 91 percent from the previous year for the first quarter...
Moderna beats estimates in Q1 2024, targets RSV vaccine launch in fall By Investing.com
Investing.com· 10 hours agoModerna Inc. (NASDAQ:MRNA) reported first-quarter earnings and revenue that came ahead of analyst...
Moderna stock surges 15% after it beat earnings expectations despite plummeting COVID vaccine sales
Quartz· 9 hours agoModerna stock soared on Wednesday after its first-quarter earnings report sailed past Wall Street’s...
Moderna Stock Jumps After Scoring an Earnings Beat. Next Up? Its RSV Shot.
Barrons.com· 6 hours agoModerna reported first-quarter financial results Thursday that soundly beat Wall Street...
Moderna quarterly sales beat expectations but plummet from previous year
Reuters via Yahoo News· 10 hours ago(Reuters) -Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came...
Is Moderna Stock A Buy On Its Eye-Popping First-Quarter Sales Beat?
Investor's Business Daily· 4 hours agoThe company noted that it achieved 48% market share for Covid vaccines in the U.S. during the fall...
Moderna posts better-than-expected quarterly results as it looks to fall RSV vaccine launch
Market Watch· 10 hours agoA Food and Drug Administration decision on approval of Moderna’s RSV vaccine is expected by May 12,...